Lang James Paul 4

What Happened James Lang, a director of OptimizeRx Corp (OPRX), received a grant of 34,517 restricted stock units (RSUs) on June 9, 2026. The units were awarded at $0.00 (i.e., no cash purchase price) and represent a contingent right to receive shares of OptimizeRx common stock once the RSUs vest. The filing does not report an immediate cash value realization—this is a compensation award rather than a purchase or sale.

Key Details

• Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 34,517 RSUs; reported acquisition price $0.00.
• Vesting: RSUs vest in full on the earlier of the first anniversary of the grant or the date of the company’s next annual meeting of shareholders (per footnote).
• Shares owned after transaction: Not specified in this filing.
• Remarks: The filer included a standard statement that the filing is not an admission of beneficial ownership for Section 16 purposes.

Context RSU grants are a form of equity compensation that convert into company shares upon vesting; they are not an immediate market purchase or sale and therefore don't directly signal a director buying stock with personal funds. For retail investors, such awards are common as compensation for service and should be viewed separately from open-market insider purchases or sales.